Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Dobbs

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Chromatography|December 6, 1991
Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processorN A Dobbs, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Comments on epirubicinN A Dobbs, C J Twelves
British Journal of Cancer|May 6, 1998
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?N A Dobbs, C J Twelves
Journal of Chromatography|September 4, 1987
Estimation of doxorubicin and doxorubicinol by high-performance liquid chromatography and advanced automated sample processorN A Dobbs, C A James
British Journal of Cancer|September 23, 1998
What is the effect of adjusting epirubicin doses for body surface area?N A Dobbs, C J Twelves
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification schemeN A Dobbs, C J Twelves, W Gregory, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistryN A Dobbs, C J Twelves, H Gillies, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerC J Twelves, N A Dobbs, M Aldhous, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancerN A Dobbs, C J Twelves, A J Ramirez, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry testsC J Twelves, N A Dobbs, H C Gillies, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Chromatography|December 6, 1991
Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processorN A Dobbs, C J Twelves
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Comments on epirubicinN A Dobbs, C J Twelves
British Journal of Cancer|May 6, 1998
Anthracycline doses in patients with liver dysfunction: do UK oncologists follow current recommendations?N A Dobbs, C J Twelves
Journal of Chromatography|September 4, 1987
Estimation of doxorubicin and doxorubicinol by high-performance liquid chromatography and advanced automated sample processorN A Dobbs, C A James
British Journal of Cancer|September 23, 1998
What is the effect of adjusting epirubicin doses for body surface area?N A Dobbs, C J Twelves
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification schemeN A Dobbs, C J Twelves, W Gregory, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistryN A Dobbs, C J Twelves, H Gillies, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative pharmacokinetics of doxorubicin given by three different schedules with equal dose intensity in patients with breast cancerC J Twelves, N A Dobbs, M Aldhous, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Patient acceptability and practical implications of pharmacokinetic studies in patients with advanced cancerN A Dobbs, C J Twelves, A J Ramirez, et al.
Cancer Chemotherapy and Pharmacology|July 31, 1998
Doxorubicin pharmacokinetics: the effect of abnormal liver biochemistry testsC J Twelves, N A Dobbs, H C Gillies, et al.
Pageof 2